Michigan State University describes new MAPT aggregation inhibitors for Alzheimer’s disease
April 21, 2023
Michigan State University has identified microtubule-associated protein tau (PHF-tau; MAPT) aggregation inhibitors reported to be useful for the treatment of Alzheimer’s disease.